Director of Gynecological Pathology
Open date: August 5, 2022
Most recent review date: Sunday, Jan 15, 2023 at 11:59pm (Pacific Time)
Applications received after this date will be reviewed by the search committee if the position has not yet been filled.
Final date: Friday, Jun 30, 2023 at 11:59pm (Pacific Time)
Applications will continue to be accepted until this date, but those received after the review date will only be considered if the position has not yet been filled.
The Department of Pathology and Laboratory Medicine at the University of California, Irvine is seeking qualified candidates for appointment at the Assistant, Associate or Full Professor level to serve as the Director of Gynecological Pathology. The academic appointment may be in the Health Sciences (HS) Clinical or Clinical X series, depending on experience and extent of research effort. Both HS and Clinical X faculty provide patient care; teach fellows, residents, and medical students; perform public and University service; and contribute to scholarly activities, but Clinical X faculty are expected to conduct more substantial research.
Applicants must have significant experience and/or fellowship training in gynecologic pathology, hold an MD, DO, or MD/PhD degree, and must be board-certified or board-eligible in Anatomic Pathology. The successful candidate is expected to have excellent interpersonal and managerial skills, a strong interest in service activities, a commitment to education, and a record in clinical and/or translational research that may be collaborative in nature. The candidate will be responsible for clinical services in gynecological and surgical pathology, including on-call duty, service on departmental and hospital committees, and teaching and mentoring of medical students, residents, and fellows.
Founded in 1965, UCI is a top hospital and top-10 public university in U.S. News & World Report and home to several NIH-funded centers, including the Chao Family Comprehensive Cancer Center (CFCCC) and Institute for Clinical and Translational Sciences (ICTS). With philanthropic support, the UCI School of Medicine is now joined by the Samueli Institute for Integrative Health and new Schools of Nursing, Pharmacy & Pharmaceutical Sciences, and Population & Public Health in the UCI College of Health Sciences. UCI Health physicians in Obstetrics and Gynecology services excel in all areas of gynecologic care, including high-risk maternal-fetal services, gynecologic cancer, urogynecology and general gynecology care. UCI Medical Center also has been named one of America’s best maternity care hospitals by U.S. News and Newsweek for 2022. As the centerpiece for UCI’s Brilliant Future campaign, a new hospital complex on the Irvine-Newport Beach campus is under construction and scheduled to begin operations in 2023. UCI Health is the only academic medical center in Orange County, the nation’s 6th largest county and one of the most desirable locations to live in the US. In support of its diverse citizenry, UCI is Orange County’s largest employer, contributing $7 billion annually to the local economy and $8 billion statewide.
Requirements - All applicants must have significant experience and/or fellowship training in gynecological pathology, must be board-certified or board-eligible in Anatomic Pathology, and must hold or qualify for a medical license in the State of California. Salary and rank are commensurate with experience.
TO APPLY: Please log onto UCI’s RECRUIT located at https://recruit.ap.uci.edu/JPF07806
Applicants should complete an online application profile and upload application materials electronically to be considered for the position:
- Curriculum vitae & cover letter
- Names and addresses of four references
- Statement of teaching
- Statement of contributions to diversity
Applicants must have significant experience and/or fellowship training in gynecologic pathology, hold an MD, DO, or MD/PhD degree, and must be board-certified or board-eligible in Anatomic Pathology. Must hold or qualify for a medical license in the State of California.
Curriculum Vitae - Your most recently updated C.V.
Statement of Research (Optional)
Teaching Statement - See our guidance for writing a reflective teaching statement.
Inclusive Excellence Activities Statement - Statement addressing how past and/or potential contributions to inclusive excellence will advance UCI's Commitment to Inclusive Excellence. See our guidance for writing an inclusive excellence activities statement.
Misc / Additional (Optional)
- 4 required (contact information only)
The University of California, Irvine is an Equal Opportunity/Affirmative Action Employer advancing inclusive excellence. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, age, protected veteran status, or other protected categories covered by the UC nondiscrimination policy.
As a condition of employment, you will be required to comply with the University of California Policy on Vaccination Programs – With Updated Interim Amendments. All Covered Individuals under the policy must provide proof of receiving the COVID-19 Vaccine Primary Series or, if applicable, submit a request for Exception (based on Medical Exemption, Disability, Religious Objection, and/or Deferral based on pregnancy or recent COVID-19 diagnosis and/or treatment) no later than the applicable deadline. All Covered Individuals must also provide proof of receiving the most recent CDC-recommended COVID-19 booster or properly decline such booster no later than the applicable deadline. New University of California employees should refer to Exhibit 2, Section II.C. of the SARS-CoV-2 (COVID-19) Vaccination Program Attachment for applicable deadlines. All Covered Individuals must also provide proof of being up-to-date on seasonal influenza vaccination or properly decline such vaccination no later than the applicable deadline. Please refer to the Seasonal Influenza Vaccination Program Attachment. (Capitalized terms in this paragraph are defined in the policy.) Federal, state, or local public health directives may impose additional requirements.